Cargando…

Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists

SIMPLE SUMMARY: The immune system is capable of eliminating solid cancers through the action of immune cells that recognise antigens that are unique to tumour tissue. However, the activity of tumour-specific immune cells is often blunted by the immunosuppressive environment within the tumour core. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burn, Olivia K., Prasit, Kef K., Hermans, Ian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765936/ https://www.ncbi.nlm.nih.gov/pubmed/33352882 http://dx.doi.org/10.3390/cancers12123824

Ejemplares similares

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors
por: Agrawal, Sudhir, et al.
Publicado: (2019)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Local hypoxia is produced at sites of intratumour injection
por: Olive, P L, et al.
Publicado: (2002)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021)

The intratumour microbiota and neutrophilic inflammation in squamous cell vulvar carcinoma microenvironment
por: Rustetska, Natalia, et al.
Publicado: (2023)

Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
por: Larsen, R. H., et al.
Publicado: (1998)

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
por: Rotman, J., et al.
Publicado: (2018)

CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumours
por: Vogl, T J, et al.
Publicado: (2002)

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021)

Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial
por: Schmidt, J, et al.
Publicado: (2007)

Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model
por: Iwai, Tadashi, et al.
Publicado: (2020)

Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane
por: Cantini, Giulia, et al.
Publicado: (2023)

Intratumoural injection of absolute alcohol in carcinoma of gastroesophageal junction for palliation of dysphagia
por: Ramakrishnaiah, Vishnu Prasad Nelamangala, et al.
Publicado: (2014)

Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
por: Brown, Graham K., et al.
Publicado: (2022)

Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity
por: Dongye, Zhangchi, et al.
Publicado: (2022)

Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Intratumour microbiome of pancreatic cancer
por: Guan, Shi-Wei, et al.
Publicado: (2023)

Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
por: Ong, Guang Han, et al.
Publicado: (2021)

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
por: Koukourakis, M I, et al.
Publicado: (2000)

Leveraging single‐cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers
por: Bowes, Amy L, et al.
Publicado: (2022)

Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
por: Brown, Graham K., et al.
Publicado: (2021)

Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
por: Agarwal, Yash, et al.
Publicado: (2022)

Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing
por: Hoover, Ashley R., et al.
Publicado: (2022)

Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation
por: Li, Yu-Tung, et al.
Publicado: (2016)

Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
por: Zalba, Sara, et al.
Publicado: (2021)

Intrahepatic fetus: unusual image of an intratumoural haemorrhage
por: Reyes, Queennie, et al.
Publicado: (2017)

Producing the appropriate model and drug for intratumoural ablation
por: Kosmidis, Christoforos, et al.
Publicado: (2020)

Intratumoural microbiota: from theory to clinical application
por: Ji, Hao, et al.
Publicado: (2023)

Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts
por: Graff, B A, et al.
Publicado: (2003)

Feasibility of CT quantification of intratumoural (166)Ho-microspheres
por: C. Bakker, R., et al.
Publicado: (2020)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
por: Wegert, Jenny, et al.
Publicado: (2017)

Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours
por: Ilie, Mirela Diana, et al.
Publicado: (2022)

Focus on pattern recognition receptors to identify prognosis and immune microenvironment in colon cancer
por: Ren, Pengtao, et al.
Publicado: (2022)

Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming
por: Aleynick, Mark, et al.
Publicado: (2023)

Principles of agonist recognition in Cys-loop receptors
por: Lynagh, Timothy, et al.
Publicado: (2014)

Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
por: Sharifi‐Salamatian, Vénus, et al.
Publicado: (2000)

popFBA: tackling intratumour heterogeneity with Flux Balance Analysis
por: Damiani, Chiara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ia0km4hs0clpms4ljrlfoua3b